Analyst consensus rating
Astrana Health Analyst Rating: Strong Buy
ASTH is rated Strong Buy by 8 analysts with a $51.50 target. As of 2026-08-23.
Direct answer
Astrana Health's consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $51.50.
Forecast evidence checked August 23, 2026.
Get free Astrana Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $39.35
- Average price target
- $51.50
- High price target
- $65.00
- Low price target
- $41.00
- Low target gap
- +4.2%
- Target upside
- +30.9%
- High target gap
- +65.2%
- Target range width
- 61%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Astrana Health?
Astrana Health has a verified Strong Buy consensus. The same dataset has an average price target of $51.50.
How far are Astrana Health's low and high targets from the recorded price?
The low target implies +4.2%, while the high target implies +65.2%.
How many analysts are included in Astrana Health's consensus?
The verified consensus includes 8 analysts.
How is Astrana Health's target upside or downside calculated?
The average target of $51.50 is divided by the recorded price of $39.35, then one is subtracted to produce +30.9%. This does not guarantee a future return.
When was Astrana Health's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.